Furthermore, in the late phase of peritonitis, TRPV1 was found to have an anti-inflammatory effect on the spleen, resulting in reduced levels of pro-inflammatory cytokines TNF-α, IL-6, IL-10 and IFN-γ. The gene discussed is TRPV1; the disease is peritonitis.